Literature DB >> 19091845

No TGFBRII germline mutations in juvenile polyposis patients without SMAD4 or BMPR1A mutation.

L A A Brosens, W A van Hattem, M C E Kools, C Ezendam, F H Morsink, W W J de Leng, F M Giardiello, G J A Offerhaus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19091845      PMCID： PMC2703607          DOI： 10.1136/gut.2008.161232

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  16 in total

1.  TGF beta signaling in health and disease.

Authors:  Rosemary J Akhurst
Journal:  Nat Genet       Date:  2004-08       Impact factor: 38.330

2.  Molecular classification of the inherited hamartoma polyposis syndromes: clearing the muddied waters.

Authors:  C Eng; H Ji
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

3.  HNPCC associated with germline mutation in the TGF-beta type II receptor gene.

Authors:  S L Lu; M Kawabata; T Imamura; Y Akiyama; T Nomizu; K Miyazono; Y Yuasa
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

4.  Germline mutation analysis of the transforming growth factor beta receptor type II (TGFBR2) and E-cadherin (CDH1) genes in early onset and familial colorectal cancer.

Authors:  L Verma; T R Porter; F M Richards; M H Rajpar; D G Evans; F Macdonald; E R Maher
Journal:  J Med Genet       Date:  2001-02       Impact factor: 6.318

5.  Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.

Authors:  K H Shin; Y J Park; J G Park
Journal:  Clin Cancer Res       Date:  2000-02       Impact factor: 12.531

6.  TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia.

Authors:  Neil A Bhowmick; Anna Chytil; David Plieth; Agnieszka E Gorska; Nancy Dumont; Scott Shappell; M Kay Washington; Eric G Neilson; Harold L Moses
Journal:  Science       Date:  2004-02-06       Impact factor: 47.728

7.  Heterozygous TGFBR2 mutations in Marfan syndrome.

Authors:  Takeshi Mizuguchi; Gwenaëlle Collod-Beroud; Takushi Akiyama; Marianne Abifadel; Naoki Harada; Takayuki Morisaki; Delphine Allard; Mathilde Varret; Mireille Claustres; Hiroko Morisaki; Makoto Ihara; Akira Kinoshita; Koh-ichiro Yoshiura; Claudine Junien; Tadashi Kajii; Guillaume Jondeau; Tohru Ohta; Tatsuya Kishino; Yoichi Furukawa; Yusuke Nakamura; Norio Niikawa; Catherine Boileau; Naomichi Matsumoto
Journal:  Nat Genet       Date:  2004-07-04       Impact factor: 38.330

8.  The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations.

Authors:  J R Howe; M G Sayed; A F Ahmed; J Ringold; J Larsen-Haidle; A Merg; F A Mitros; C A Vaccaro; G M Petersen; F M Giardiello; S T Tinley; L A Aaltonen; H T Lynch
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

9.  A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4).

Authors:  Carol J Gallione; Gabriela M Repetto; Eric Legius; Anil K Rustgi; Susan L Schelley; Sabine Tejpar; Grant Mitchell; Eric Drouin; Cornelius J J Westermann; Douglas A Marchuk
Journal:  Lancet       Date:  2004-03-13       Impact factor: 79.321

10.  CDX2 mutations do not account for juvenile polyposis or Peutz-Jeghers syndrome and occur infrequently in sporadic colorectal cancers.

Authors:  K L Woodford-Richens; S Halford; A Rowan; S Bevan; L A Aaltonen; H Wasan; D Bicknell; W F Bodmer; R S Houlston; I P Tomlinson
Journal:  Br J Cancer       Date:  2001-05-18       Impact factor: 7.640
View more
  3 in total

1.  Histologic variations in juvenile polyp phenotype correlate with genetic defect underlying juvenile polyposis.

Authors:  Willem Arnout van Hattem; Danielle Langeveld; Wendy W J de Leng; Folkert H Morsink; Paul J van Diest; Christine A Iacobuzio-Donahue; Francis M Giardiello; G Johan A Offerhaus; Lodewijk A A Brosens
Journal:  Am J Surg Pathol       Date:  2011-04       Impact factor: 6.394

Review 2.  Juvenile polyposis syndrome.

Authors:  Lodewijk Aa Brosens; Danielle Langeveld; W Arnout van Hattem; Francis M Giardiello; G Johan A Offerhaus
Journal:  World J Gastroenterol       Date:  2011-11-28       Impact factor: 5.742

3.  Precancerous lesions in colorectal cancer.

Authors:  Fayez Sandouk; Feras Al Jerf; M H D Bassel Al-Halabi
Journal:  Gastroenterol Res Pract       Date:  2013-05-14       Impact factor: 2.260
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.